跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,049 条关于
“atrioventricular reentrant tachycardia”
全部
1,049
临床试验
907
药物
12
机构
0
资讯
130
去年
Stereotaxis' Magbot Magnetic Ablation Catheter Approved in China
去年
Stereotaxis MAGiC Catheter Demonstrates 94% Acute Efficacy in First-in-Human Cardiac Ablation Study
去年
Medtronic's Affera System Receives FDA Approval for Atrial Fibrillation and Flutter Treatment
去年
FDA Approves AOP Health's Rapiblyk (Landiolol) for Supraventricular Tachycardia in Critical Care
5个月前
FDA Approves Rapiblyk for Pediatric Supraventricular Tachycardia, Marking First U.S. Treatment Option
4个月前
Proton Beam Therapy Shows Promise as Noninvasive Treatment for Refractory Ventricular Tachycardia
4年前
Eagle Pharmaceuticals Submits NDA for Landiolol, Ultra-Short-Acting Beta Blocker for Critical Care Tachycardia
去年
FDA Approves Rapiblyk (landiolol) for Supraventricular Tachycardia
去年
Medtronic's Affera System Receives FDA Approval for Ventricular Tachycardia Treatment Study
11年前
Landiolol Effectively Manages Post-Operative Supraventricular Tachycardia After Lung Resection
第 1 页，共 13 页
上一页
下一页
